Skip to main content

HPV diagnosis: What tests are available and how HPV is detected

Advertisement

How is HPV diagnosed?

A diagnosis of human papillomavirus (HPV) infection is usually not made by means of a conventional blood test, but through targeted examinations of the affected areas of skin or mucous membranes. In Austria, a modernised screening programme for the diagnosis of HPV has been in place since 2024. Unlike in the past, the HPV test is now the primary method of cancer screening for women aged 30 and over.

Pap test for women aged 20 to 29

For women aged 20 to 29, the traditional cervical smear, also known as a Pap test, remains the standard. It is recommended annually.

During a Pap test, cells are taken from the cervix and then examined under a microscope. This allows any potential cell changes to be detected at an early stage.

HPV test for women aged 30 and over

For women aged 30 and over, the HPV test replaces the annual Pap test as the primary service covered by health insurance. If the test is negative, a three-year interval until the next test is sufficient. This is because the risk of cancer developing rapidly is very low if the test is negative for the virus.

If the HPV test is positive, a Pap smear is also carried out. This helps to determine whether the virus has already caused any cell changes.

Diagnosis of genital warts and other visible symptoms

In the case of visible symptoms such as genital warts, the diagnosis is usually made directly in a dermatologist’s or gynaecologist’s surgery through visual examination. The warts are identified by sight.

Depending on the location and symptoms, further investigations may be advisable. These include, for example, a rectal examination or an examination of the anal canal and rectum using a scope. These procedures are known as anoscopy and proctoscopy respectively.

How dangerous is an HPV infection?

HPV affects almost everyone. Around 80 per cent of all sexually active people become infected with HPV viruses at some point in their lives. The good news is that the body usually clears the virus on its own. In such cases, no illness develops and immunity to that particular HPV type often builds up.

It can become dangerous if the infection becomes chronic and the virus remains in the cells for years. However, even in this case, there are both harmless and serious consequences.

A distinction is made between:

  • Low-risk types: These are generally not medically dangerous, but can cause genital warts. Whilst these are a nuisance and can be psychologically distressing, they almost never lead to cancer.
  • High-risk types: These types, particularly HPV 16 and 18, pose the real risk. If they remain undetected in the body for years, they can alter the cell’s DNA. This can lead to precancerous changes and ultimately to malignant tumours – primarily cervical cancer, but also tumours in the mouth and throat, on the anus or on the penis.

It is therefore not the infection itself that is dangerous, but rather the fact that high-risk viruses remain undetected in the body for many years. Regular screening helps to detect cell changes at an early stage.

How high is the risk of cancer with HPV?

HPV infections are very common, but they rarely lead to cancer. In most cases, the immune system clears the viruses on its own. Regular screening can prevent cervical cancer in many cases.

It is important to note that, of the more than 200 types of HPV, around 14 are considered carcinogenic. HPV types 16 and 18 are among the so-called high-risk types and are responsible for around 70 to 80 per cent of all cases of cervical cancer. Together with types 31, 33, 45, 52 and 58, they cause around 90 per cent of malignant changes.

However, it is crucial to note that a short-term HPV infection does not usually lead to cancer. Cell changes usually only occur when high-risk HPV remains in the mucous membrane for a prolonged period.

Smoking is an additional risk factor. It can weaken the local immune defences in the mucous membranes, thereby making it more likely that an HPV infection will persist for longer.

The HPV screening process at the gynaecologist’s

The procedure for an HPV test at the gynaecologist’s is straightforward and usually takes only a few minutes. The test forms part of the standard gynaecological screening, also known as the cervical smear.

Here is the step-by-step procedure:

  • Medical history interview: During this, the doctor will ask about any symptoms, such as breakthrough bleeding or visible changes. The date of the last examination and vaccination status, particularly regarding the HPV vaccine, will also be discussed.
  • Gynaecological examination: The doctor examines the outer labia and the vaginal opening for any visible changes, such as genital warts. A speculum is then carefully inserted. This allows the cervix to be seen.
  • Sample collection / smear test: For the smear test, the doctor uses a small brush or a cotton swab. This is gently swabbed across the surface of the cervix and into the cervical canal. The cells collected are then placed in a tube containing liquid or smeared onto a glass slide.
  • Laboratory examination: In Austria, the sample is then sent to the laboratory. What is examined there depends on the age of the person being tested. For those under 30, a Pap test is usually carried out as the primary test. This involves examining the cells for any abnormalities. An HPV test is usually only carried out if abnormalities are found. From the age of 30, an HPV test is carried out as the primary screening. In this test, the laboratory looks directly for the DNA of high-risk HPV types.
  • Results: Results are usually available after seven to 14 days. If the results are normal, you will often not be contacted directly. If the results are abnormal, a consultation or a more detailed examination will take place, such as a colposcopy. During this procedure, the cervix is examined using a special magnifying lens.

Important: A positive HPV result does not mean that you have cancer. Often, it simply means that the area should be monitored more closely. You can read more about this here.

Pap test

The Pap test, also known as a cervical smear, is a simple and generally painless examination. During the test, cells are collected from the surface of the cervix and from the cervical canal using a small brush.

The sample is then sent to a laboratory for further analysis. This enables cell changes to be detected at an early stage and any precancerous changes in the cervix to be identified.

Pap smear results

Broadly speaking, the following result categories are distinguished:

  • PAP 0: The smear cannot be assessed and should be repeated at an early date.
  • PAP I: Normal, healthy cell pattern
  • PAP II: PAP II indicates certain cellular changes. However, there is no suspicion of cervical cancer or its precursors. PAP I and PAP II are considered normal results. A repeat smear is usually only required at the next gynaecological screening appointment.
  • PAP III: PAP III indicates changes whose benign nature cannot be reliably assessed. Although no cancer cells were detected in the cell sample, the cellular changes observed cannot be clearly classified.
  • PAP IIID: PAP IIID indicates mild to moderate dysplasia. This means that there are mild cellular changes which may correspond to possible precancerous lesions. However, there is no cancer present. There is a low risk that cancer cells may develop.
  • PAP IV: There are marked cellular changes or possible precancerous lesions.
  • PAP V: There is a higher probability that cancer has developed.

In the case of precancerous lesions, a further distinction is made between CIN I, CIN II and CIN III. These correspond to low-grade, moderate and severe dysplasia.

An abnormal Pap smear result may indicate mild to pronounced cellular changes. However, it does not automatically mean that cervical cancer is present.

Nor is a Pap smear result alone sufficient to diagnose cervical cancer. Depending on the results, further investigations may be necessary. These may include, for example, a repeat smear test after some time, a colposcopy, viral typing, cervical biopsies or treatment with medication.

HPV test

An HPV test is carried out in a similar way to a Pap smear. Cells are collected and then examined in the laboratory.

The HPV test is used to detect human papillomaviruses. An HPV test can usually also determine whether there is an infection with the two particularly significant high-risk types, HPV 16 and HPV 18, or whether there is an infection with another high-risk HPV type.

This information can be used specifically to better assess the chances of spontaneous resolution in the event of dysplasia. With HPV 16 and HPV 18, for example, these chances are lower than with some other types. Furthermore, the result helps to plan the next steps more effectively.

By detecting an HPV infection, the risk of developing cervical cancer can be assessed at an early stage. If the HPV test is negative, it can be assumed with a high degree of probability that there are no precancerous changes in the cervix.

However, a positive HPV test result does not provide certainty as to whether precancerous cervical lesions are already present. Further investigations are required for this.

HPV tests are now available that make it possible to:

  • to assess which women are at increased risk of developing cervical cancer
  • identify HPV genotypes 16 and 18, thereby enabling women at particularly high risk to be identified more reliably
  • spare women without an increased risk potentially unnecessary further investigations or treatment
HPV-Test - Laborproben
Photo: StanislavSukhin/shutterstock

Pap test and HPV test: what is the difference?

The difference can be explained simply as follows:

  • The Pap test detects changes that have already occurred, i.e. abnormal or damaged cells.
  • The HPV test detects the potential cause – the virus – often before any cell changes occur.
Characteristic Pap test HPV test
What is being tested for? Cellular
changes (under the microscope)
Viral genetic material (DNA/RNA in the laboratory)
Research
question
Are the cells currently affected? Is the high-risk virus present?
Advantage Detects acute inflammation/cancer Detects danger before cells become diseased
Frequency Annually (for women aged 20–29) Every 3 years (standard from age 30)

How reliable are the tests?

Both tests are highly reliable. However, they ‘work’ in different ways. In medicine, these are referred to as sensitivity and specificity.

  • HPV test: The HPV test has very high sensitivity. This means that it almost always detects the virus when it is present. A negative HPV test therefore provides a very high degree of certainty that there is only a very low risk of cervical cancer in the coming years. The downside is that the HPV test has lower specificity. This means it can also return a positive result in cases of infection that the body is currently fighting off itself and which have not yet caused any damage. This can sometimes lead to a ‘false alarm’.
  • Pap test: The Pap test has high specificity. If the results are abnormal, there are usually actual cell changes present. The disadvantage is that its sensitivity is lower than that of the HPV test. This means that minor or early changes can sometimes be overlooked.

In Austria, a Pap test is often carried out in addition to an HPV test for women aged 30 and over if the HPV test is positive. This combination is particularly useful: the HPV test shows whether a relevant virus is present. The Pap test then checks whether the virus has already caused cellular changes.

What happens if the results are abnormal?

If the results are abnormal – for example, a Pap III result or a positive HPV test – a standardised investigation process begins. This does not mean that cancer is present. It simply means, at this stage, that the findings should be examined more closely. The typical procedure consists of

  • Colposcopy: The doctor examines the cervix using a magnifying device known as a colposcope. Often, a contrast solution is also applied to make any abnormal areas more visible.
  • Biopsy, if necessary: If any suspicious areas are visible, a small tissue sample is taken. This procedure is usually only slightly painful and provides a more accurate diagnosis.

If there are no changes, or only minor ones, a wait and see approach is often sufficient. The reason is that, in many cases, the body fights off the virus itself. In the event of more significant changes – that is, more pronounced dysplasia – the affected tissue can be removed in a short, usually outpatient procedure. This procedure is called conisation.

Important to know: Cervical cancer does not usually develop suddenly. It usually takes many years for an HPV infection to develop into cancer. This is precisely why screening is so effective: abnormal cell changes can be detected and treated long before cancer develops.

Treatments for HPV

Treatment depends on the severity of the cellular changes, i.e. the respective CIN stage.

  • Watchful waiting (‘wait and see’): In the case of mild changes, i.e. CIN I, a ‘wait and see’ approach is usually adopted initially. The immune system often reverses such changes on its own. Regular check-ups are important in this case.
  • Conisation: In the case of moderate to severe changes, i.e. CIN II or CIN III, a conisation may be necessary. During this procedure, the doctor removes the affected area of the cervix in a cone-shaped section. It is a minor, routine procedure, usually carried out on an outpatient basis, often under short-acting anaesthesia. The aim is to safely remove the abnormal tissue.
  • Wart removal: Genital warts can either be treated at home with special creams or removed at the doctor’s surgery. Options include, for example, cryotherapy, laser treatment or other medical procedures.

HPV diagnosis in men

Unlike gynaecological screening, there is currently no routine screening recommendation for HPV in men. If a doctor detects an HPV infection in a man, this is usually not the result of a preventive test, but rather due to symptoms.

In the case of visible changes, such as genital warts, a visual diagnosis by an experienced specialist – for example, a urologist or dermatologist – is often sufficient.

If a skin lesion appears unclear, the doctor may take a tissue sample and have it examined pathologically. This allows malignant changes to be ruled out. This examination is called a biopsy. HPV DNA testing is usually only carried out in individual cases, such as when findings are diagnostically unclear or in specific high-risk situations.

The best form of prevention is therefore the HPV vaccination. It protects against the main types of HPV that can cause genital warts and certain types of cancer. The vaccination may also be beneficial for adult men. You can read more about HPV in men here.

HPV beim Mann: Arzt erklärt einem männlichen Patienten den Befund
Photo: Evgeny Atamanenko/shutterstock

Can you test for HPV yourself at home?

  • For women: There are approved home self-tests where you take a vaginal swab yourself. These tests can be a useful addition, but they are by no means a substitute for a regular gynaecological check-up.
  • For men: There are currently no generally recommended HPV self-tests for men. They are considered unreliable and usually do not provide results that can be used for treatment.

Tip: If you have any concerns, consult a doctor, such as a gynaecologist, urologist or dermatologist. The HPV vaccine is the most important medically recognised measure for preventing HPV-related diseases. Tests, on the other hand, are primarily used for early detection or diagnostic purposes.

Preventing HPV: vaccination, condoms and screening

HPV cannot be completely avoided. However, the risk of infection and of HPV-related diseases can be significantly reduced. The most important measures are the HPV vaccination, condoms and, for women, regular gynaecological check-ups.

HPV vaccination

The HPV vaccination is the most important preventive measure against HPV-related diseases. It protects against the main types of HPV that can cause genital warts and certain types of cancer.

These include, amongst others, cervical cancer, anal cancer, penile cancer and certain cancers of the mouth and throat.
The vaccination is recommended for people of all genders. It is most effective when administered before a person becomes sexually active. However, it can still be beneficial later on, as not everyone has already been exposed to all relevant HPV types.

In Austria, the HPV vaccination is free for people aged between 9 and 21. For people aged between 21 and 30, free first doses have not been available since 1 January 2026; those who received the first dose as part of the temporary catch-up programme by 31 December 2025 can still receive the second dose free of charge until 30 June 2026. You can read more about the HPV vaccination here.

Condoms reduce the risk

Condoms can significantly reduce the risk of HPV transmission. However, they do not offer complete protection.
The reason: HPV can also be transmitted through skin-to-skin and mucous membrane contact. Some affected areas of skin are not fully covered by condoms.

Screening detects cell changes at an early stage

Regular gynaecological screening is important for detecting cell changes in the cervix at an early stage.
Depending on your age, a Pap test, an HPV test or both may be used. Whilst screening does not prevent HPV infection, it can help to detect and treat precancerous changes in good time.

In short: the vaccine protects against the most common types of HPV. Condoms reduce the risk of transmission. Screening helps to detect any potential cell changes at an early stage.

  • Author

    Gernot Hofer

More on this topic
Hormones

Low testosterone in men: symptoms, causes and treatment

Fatigue, a reduced sex drive, and a lack of energy: these symptoms can have many causes. One possible explanation is a testosterone deficiency. However, it is not possible to determine whether testosterone levels are actually too low based solely on the symptoms or on a single blood test result.

Men's health
Men's health

PSA level: What does it mean, and when is it too high?




The PSA level is one of the best-known laboratory test results relating to the prostate. Many men come across it for the first time during a screening examination or when having symptoms investigated. An abnormal result often raises questions: Is this already a sign of prostate cancer? What levels are considered normal?

Prostate
Pollen allergy

The right diet for hay fever

Anyone suffering from hay fever should pay particular attention to their diet so as not to make the symptoms any worse.

Nutrition
Urology

Prostate health: What men need to know

The prostate is a gland in a man’s body that is only the size of a chestnut, but it plays a crucial role in well-being, urinary function and male sexuality. Benign enlargement and prostate cancer become more common in older age.

Prostate